The study authors researched Medline, Embase and Cochrane Reviews to pool results. There were 547 articles identified and 14 that were relevant to the study based on abstract review. Nine studies provided data for 558 patients undergoing a lumbar microdiscectomy.
The researchers found:
1. The clinical success rate was statistically significant at 83.5 percent.
2. There was a minimal heterogeity Q value of 7.41 and I2 value of 5.53.
3. The return-to-play odds with symptomatic lumbar disc herniation was 1.13, and there wasn’t a statistical difference between return-to-play for the operative and non-operative groups compared in four studies.
4. The more aggressive approach to symptomatic lumbar herniated nucleus pulposus for elite athletes with earlier surgical intervention “may be employed judiciously if timing necessitates for the athlete’s benefit,” concluded the study authors.
More articles on spine surgery:
Lateral spine surgery effective in an ASC: 5 key notes
Mercy Medical earns Blue Distinction for spine surgery
8 things for spine surgeons to know for Thursday
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.